Core Laboratories Stock Today

CLB
 Stock
  

USD 19.83  0.02  0.10%   

Market Performance
0 of 100
Odds Of Distress
Less than 43
Core Laboratories is trading at 19.83 as of the 4th of July 2022, a 0.10 percent up since the beginning of the trading day. The stock's open price was 19.81. Core Laboratories has about a 43 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Core Laboratories NV are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of March 2022 and ending today, the 4th of July 2022. Click here to learn more.
CUSIP
N22717107
Fiscal Year End
December
Business Domain
Energy
IPO Date
20th of September 1995
Category
Energy
Classification
Energy
ISIN
NL0000200384
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company was founded in 1936 and is based in Amstelveen, the Netherlands. The company has 46.29 M outstanding shares of which 3.96 M shares are currently shorted by investors with about 7.51 days to cover. More on Core Laboratories NV

Moving together with Core Laboratories

0.8HALHalliburton Potential GrowthPairCorr
0.81MTRXMatrix Service Fiscal Year End 12th of September 2022 PairCorr

Moving against Core Laboratories

0.51DQDaqo New Energy Tech BoostPairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Core Laboratories Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Core Laboratories' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Core Laboratories or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Core Laboratories generated a negative expected return over the last 90 days
Core Laboratories has high historical volatility and very poor performance
Core Laboratories has a strong financial position based on the latest SEC filings
Latest headline from simplywall.st: Insiders of Core Laboratories N.V. must have made a tidy sum after selling stock currently worth US19.81 at US23.33 - Simply Wall St
ChairmanLawrence Bruno
Thematic IdeaPetroleum and Natural (view all)
Fama & French Classification
Average Analyst Recommendation
Analysts covering Core Laboratories report their recommendations after researching Core Laboratories' financial statements, talking to executives and customers, or listening in on Core Laboratories' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Core Laboratories. The Core Laboratories consensus assessment is calculated by taking the average forecast from all of the analysts covering Core Laboratories.
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Core Laboratories based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Core Laboratories financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
 7 - StrongDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares43.1 M46 M
Notably Down
Decreasing
Slightly volatile
Weighted Average Shares Diluted43.6 M46.7 M
Significantly Down
Decreasing
Slightly volatile
Net Cash Flow from Operations37.5 M36.6 M
Fairly Up
Decreasing
Slightly volatile
Total Assets571.3 M580.9 M
Fairly Down
Decreasing
Stable
Total Liabilities507.5 M419.9 M
Fairly Up
Increasing
Stable
Current Assets200.1 M189.1 M
Notably Up
Decreasing
Slightly volatile
Current Liabilities96.4 M90.8 M
Notably Up
Decreasing
Slightly volatile
Total Debt300.2 M250.3 M
Fairly Up
Increasing
Stable
Return on Average Assets0.03490.034
Fairly Up
Decreasing
Slightly volatile
Gross Margin0.240.218
Significantly Up
Decreasing
Slightly volatile
Asset Turnover0.930.8
Fairly Up
Decreasing
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Core Laboratories' available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Cautious HoldUndervalued
Financial Strength
Core Laboratories' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Core Laboratories' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Core Laboratories' financial leverage. It provides some insight into what part of Core Laboratories' total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on Core Laboratories' books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Core Laboratories deploys its capital and how much of that capital is borrowed.
Liquidity
Core Laboratories cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company has 250.85 M in debt with debt to equity (D/E) ratio of 1.51, which is OK given its current industry classification. Core Laboratories has a current ratio of 1.99, which is typical for the industry and considered as normal. Debt can assist Core Laboratories until it has trouble settling it off, either with new capital or with free cash flow. So, Core Laboratories' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Core Laboratories sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Core Laboratories to invest in growth at high rates of return. When we think about Core Laboratories' use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

37.54 MillionShare
Core Laboratories NV (CLB) is traded on New York Stock Exchange in USA. It is located in Van Heuven Goedhartlaan 7 B and employs 3,600 people. Core Laboratories is listed under Petroleum and Natural category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with total capitalization of 923.48 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Core Laboratories's market, we take the total number of its shares issued and multiply it by Core Laboratories's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Core Laboratories runs under Energy sector within Oil & Gas Equipment & Services industry. The entity has 46.29 M outstanding shares of which 3.96 M shares are currently shorted by investors with about 7.51 days to cover. Core Laboratories NV has about 22.04 M in cash with 33.88 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.48.
Check Core Laboratories Probability Of Bankruptcy
Ownership
Core Laboratories holds a total of fourty-six million two hundred ninety thousand outstanding shares. The majority of Core Laboratories NV outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Core Laboratories to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Core Laboratories. Please pay attention to any change in the institutional holdings of Core Laboratories NV as this could imply that something significant has changed or about to change at the company. Also note that nearly four million one hundred sixty-six thousand one hundred invesors are currently shorting Core Laboratories expressing very little confidence in its future performance.

Ownership Allocation (%)

Check Core Laboratories Ownership Details

Core Laboratories Stock Price Odds Analysis

What are Core Laboratories' target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Core Laboratories jumping above the current price in 90 days from now is under 95%. The Core Laboratories NV probability density function shows the probability of Core Laboratories stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon the stock has a beta coefficient of 1.126 suggesting Core Laboratories NV market returns are sensitive to returns on the market. As the market goes up or down, Core Laboratories is expected to follow. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Core Laboratories is significantly underperforming DOW.
  Odds Below 19.83HorizonTargetOdds Above 19.83
5.68%90 days
 19.83 
94.29%
Based on a normal probability distribution, the odds of Core Laboratories to move above the current price in 90 days from now is under 95 (This Core Laboratories NV probability density function shows the probability of Core Laboratories Stock to fall within a particular range of prices over 90 days) .

Core Laboratories Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Core Laboratories that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Core Laboratories' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Core Laboratories' value.
InstituionSecurity TypeTotal SharesValue
Ariel Investments LlcCommon Shares8.2 M259.3 M
Blackrock IncCommon Shares5.5 M173.3 M
View Core Laboratories Diagnostics

Core Laboratories Historical Income Statement

Core Laboratories NV Income Statement is one of the three primary financial statements used for reporting Core Laboratories's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Core Laboratories revenue and expense. Core Laboratories Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Core Laboratories Consolidated Income is projected to decrease significantly based on the last few years of reporting. The past year's Consolidated Income was at 20.22 Million. The current year Cost of Revenue is expected to grow to about 412.3 M, whereas Selling General and Administrative Expense is forecasted to decline to about 42.7 M. View More Fundamentals

Core Laboratories Stock Against Markets

Picking the right benchmark for Core Laboratories stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Core Laboratories stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Core Laboratories is critical whether you are bullish or bearish towards Core Laboratories NV at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Core Laboratories without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Content Syndication Now

   

Content Syndication

Quickly integrate customizable finance content to your own investment portal
All  Next Launch Module

Core Laboratories Corporate Directors

Core Laboratories corporate directors refer to members of a Core Laboratories board of directors. The board of directors generally takes responsibility for the Core Laboratories' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Core Laboratories' board members must vote for the resolution. The Core Laboratories board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Charles Dunlap - Independent Member of the Board of Supervisory DirectorsProfile
Richard Bergmark - CFO, Executive VP and Supervisory DirectorProfile
Michael Kearney - Independent Supervisory DirectorProfile
Margaret Kempen - Independent Member of the Board of Supervisory DirectorsProfile

Investing Core Laboratories NV

You need to understand the risk of investing before taking a position in Core Laboratories. The danger of trading Core Laboratories NV is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Core Laboratories is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Core Laboratories. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Core Laboratories is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Continue to Trending Equities. Note that the Core Laboratories information on this page should be used as a complementary analysis to other Core Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Complementary Tools for Core Laboratories Stock analysis

When running Core Laboratories price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Is Core Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core Laboratories will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.81
Market Capitalization
918.6 M
Quarterly Revenue Growth YOY
0.064
Return On Assets
0.0339
Return On Equity
0.0651
The market value of Core Laboratories is measured differently than its book value, which is the value of Core Laboratories that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine Core Laboratories value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.